Clinipace Worldwide has entered a definitive merger agreement to acquire all outstanding shares of Paragon Biomedical, Inc. and its subsidiaries. The merger expands Clinipace’s therapeutic expertise, site management capabilities, and clinical operations, as well as its global footprint with offices in Irvine, CA, High Wycombe, UK, and Trivandrum, India.     “Paragon is an ideal partner to achieve our common long-term goals to drive innovation in clinical research through a technology-amplified s...